Furthermore, RT modifies the tumor microenvironment by enhancing the release of CXCL16 from tumor cells [8] and upregulating VCAM-1 on the tumor vasculature [9] to favor the recruitment and trafficking of tumor specific cytotoxic T cells to tumor tissue. The gene discussed is CXCL16; the disease is neoplasm.